Department of Medicine, University of Wisconsin School of Medicine & Public Health, Madison, Wisconsin, United States of America.
Department of Medical Microbiology and Immunology, University of Wisconsin School of Medicine & Public Health, Madison, Wisconsin, United States of America.
PLoS Pathog. 2021 Oct 21;17(10):e1009959. doi: 10.1371/journal.ppat.1009959. eCollection 2021 Oct.
Clostridioides difficile is an opportunistic diarrheal pathogen responsible for significant morbidity and mortality worldwide. A disrupted (dysbiotic) gut microbiome, commonly engendered by antibiotic treatment, is the primary risk factor for C. difficile infection, highlighting that C. difficile-microbiome interactions are critical for determining the fitness of this pathogen. Here, we review short chain fatty acids (SCFAs): a major class of metabolites present in the gut, their production by the gut microbiome, and their impacts on the biology of the host and of C. difficile. We use these observations to illustrate a conceptual model whereby C. difficile senses and responds to SCFAs as a marker of a healthy gut and tunes its virulence accordingly in order to maintain dysbiosis. Future work to learn the molecular mechanisms and genetic circuitry underlying the relationships between C. difficile and SCFAs will help to identify precision approaches, distinct from antibiotics and fecal transplant, for mitigating disease caused by C. difficile and will inform similar investigations into other gastrointestinal pathogens.
艰难梭菌是一种机会性腹泻病原体,在全球范围内造成了重大的发病率和死亡率。(肠道)微生物组的紊乱(失调),通常是由抗生素治疗引起的,是艰难梭菌感染的主要危险因素,这突出表明艰难梭菌-微生物组的相互作用对于确定该病原体的适应性至关重要。在这里,我们回顾了短链脂肪酸(SCFAs):一类存在于肠道中的主要代谢物,它们由肠道微生物组产生,以及它们对宿主和艰难梭菌生物学的影响。我们利用这些观察结果来说明一个概念模型,即艰难梭菌将 SCFAs 作为肠道健康的标志物进行感知和响应,并相应地调整其毒力,以维持微生物组失调。未来的工作需要了解艰难梭菌与 SCFAs 之间关系的分子机制和遗传回路,将有助于确定不同于抗生素和粪便移植的精准方法来减轻艰难梭菌引起的疾病,并为其他胃肠道病原体的类似研究提供信息。